Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenografts.

ABSTRACT:

SUBMITTER: Perner F 

PROVIDER: S-EPMC8209563 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature